Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Total Neoadjuvant mFOLFOX and Short-Course Radiotherapy in Resectable Rectal Cancer

NCT04643366 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT04643366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Total Neoadjuvant mFOLFOX and Short-Course Radiotherapy in Resectable Rectal Cancer
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Recruiting
Start date
January 28, 2021
Completion date
January 31, 2032
Enrollment
64 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer